Clinical Trials Browser

Phase 1 × Neoplasms, Plasma Cell × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all

NCT00477815 2018-05-14

Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan, Melphalan, and Autologous Peripheral Stem Cell Transplant in Treating Patients With Previously Treated Multiple Myeloma

Phase 1 Completed

Multiple Myeloma, Neoplasms, Plasma Cell